TraceLink to Present at the 38th Annual J.P. Morgan Healthcare Conference

NORTH READING, Mass., Jan. 8, 2020 /PRNewswire/ — TraceLink Inc., a network-based platform company with the world’s largest integrated digital supply network for life sciences, today announced that Shabbir Dahod, president and CEO of TraceLink, will present at the 38th Annual J.P. Morgan Healthcare Conference for the fourth consecutive year. His presentation will take place on Tuesday, January 14, at 5 p.m. PST at the Westin St. Francis in San Francisco.

During his presentation, Dahod will discuss the long-term global market opportunity for TraceLink’s Digital Network Platform, including the Company’s expansion into additional business areas and offerings, including Networked Health, Intelligent Supply Network, Smart Supply and Logistic, and End-to-End Supply Network Digitalization solutions, and TraceLink’s unique position in transforming the healthcare industry with its patient-centric digital supply network.

About TraceLink
TraceLink is a network-based platform company that leverages its digital supply network and digital network platform to bend the supply chain around the patient. Through its industry-leading digital supply network, the TraceLink Digital Network Platform can enable seamless data sharing and process orchestration across the entire healthcare industry, enabling the creation of a real-time, patient-driven supply network. Leading life science companies, hospitals and retail pharmacies trust TraceLink to deliver complete global connectivity, visibility and traceability of pharmaceuticals, ensuring that every patient gets the medicines they need, when they need them, safely and securely. For more information on TraceLink and our solutions, visit www.tracelink.com.

TraceLink is funded by Georgian Partners, Willett Advisors LLC, Vulcan Capital, Goldman Sachs, FirstMark CapitalVolition Capital and F-Prime Capital.

View original content:http://www.prnewswire.com/news-releases/tracelink-to-present-at-the-38th-annual-jp-morgan-healthcare-conference-300983285.html

SOURCE TraceLink

Staff

Recent Posts

Hemogenyx Pharmaceuticals PLC – Issue of Equity

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE…

16 minutes ago

1933 Industries Announces Maturity of Unsecured Convertible Debentures and Encourages Conversion to Support Continued Growth

VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / 1933 Industries Inc. (the "Company"…

16 minutes ago

Bupa Hong Kong has selected Cognizant to deliver an AI-driven BPaaS solution to transform health insurance claims

Strategic collaboration aims to enhance operational efficiency and mitigate risks by transitioning to a business…

3 hours ago

DiagnosTear Signs Non-Binding Term Sheet with Sheba Impact and Ramot to Exclusively License New Eye Imaging Technology, CLARIFY, Enabling Needle-Free Blood Count

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

9 hours ago

CranioSense Awarded $5.5 Million in Federal Grants to Validate Noninvasive Neurotech

BOSTON, Dec. 17, 2025 /PRNewswire/ -- CranioSense, Inc., a neurotechnology company developing the world's first noninvasive…

9 hours ago

Therap Services Announces 2026 National Conference Schedule: Highlighting New Tools, Best Practices, and Over 250 Specialized Sessions

TORRINGTON, Conn., Dec. 17, 2025 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic…

9 hours ago